Structure via PubChem · Public domain (PubChem)
AR-R17779
Sign in to saveAR-R17779 is a drug that acts as a potent and selective full agonist for the α7 subtype of neural nicotinic acetylcholine receptors. It has nootropic effects in animal studies, but its effects do not substitute for those of nicotine. It has also been studied as a potential novel treatment for arthritis.
Chemical data
- Formula
- C9H14N2O2
- Molecular weight
- 182.22 g/mol
- IUPAC name
- (5S)-spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one
- SMILES
- C1CN2CCC1[C@@]3(C2)CNC(=O)O3
- InChIKey
- TYAGAVRSOFABFO-VIFPVBQESA-N
- XLogP
- 0.2
- Polar surface area
- 41.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Mass
- 182.105528
Show 5 more facts
- chemical formula
- C₉H₁₄N₂O₂
- canonical SMILES
- C1CN2CCC1C3(C2)CNC(=O)O3
- isomeric SMILES
- C1CN2CCC1[C@@]3(C2)CNC(=O)O3
- Commons category
- AR-R17779
- subject has role
- nootropic
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
AR-R17779 is a drug that acts as a potent and selective full agonist for the α7 subtype of neural nicotinic acetylcholine receptors. It has nootropic effects in animal studies, but its effects do not substitute for those of nicotine. It has also been studied as a potential novel treatment for arthritis.
== References==
Excerpted from Wikipedia’s “AR-R17779” article, available under the CC BY-SA 4.0 licence.